Found: 3
Select item for more details and to access through your institution.
Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11312-4
- By:
- Publication type:
- Article
Comparison of first-line immunotherapy efficacy between advanced lung squamous cell carcinoma and pulmonary lymphoepithelioma-like carcinoma: A propensity score matching multicenter study.
- Published in:
- Journal of Cancer Research & Therapeutics, 2023, v. 19, n. 4, p. 1011, doi. 10.4103/jcrt.jcrt_2711_22
- By:
- Publication type:
- Article
Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231206282
- By:
- Publication type:
- Article